Valion Bio Inc

VBIO USD0.0001
Create an alert
Sell$0.12
Buy$0.12
$0.01 (10.71%)
Last updated today at
Back to dashboard

Company Information

About this company

Valion Bio, Inc., formerly Tivic Health Systems, Inc., is a late-stage immunotherapeutics company. The Company offers Entolimod, which is a drug used to treat acute radiation syndrome (ARS). Entolimod is a toll-like receptor 5 (TLR5) agonist that activates an innate immune pathway to prevent cell death in the bone marrow and epithelial tissues across systems impacted by radiation and age. Its pipeline also includes Entolimod to treat neutropenia and lymphocyte exhaustion, as well as Entolasta, an immunologically optimized variant of Entolimod for chronic applications. Its subsidiary, Velocity Bioworks, is a full-service contract development and manufacturing organization (CDMO) that is based in San Antonio, Texas. It offers upstream and downstream process development and optimization; analytical testing, assay development, and qualification; quality control and stability testing; microbial and mammalian expression systems; technology transfer and program management services.

Key people

Sheryle J. Bolton
Independent Chairman of the Board
Lisa Wolf
Chief Financial Officer, Chief Operating Officer
Christina Valauri
Independent Director
Dean Zikria
Independent Director
Click to see more

Key facts

  • Shares in issue
    22.19m
  • EPIC
    VBIO
  • ISIN
    US8887053085
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $2.98m
  • Employees
    52
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.